NCT00118794View on ClinicalTrials.gov

Lapdap and Coartemether for Uncomplicated Malaria

PHASE3CompletedINTERVENTIONAL

Enrollment

1,200

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

June 30, 2005

Conditions

Malaria

Interventions

DRUG

Chlorproguanil-dapsone (Lapdap)

DRUG

Lumefantrine-artemether (Coartemether )

Trial Locations (1)

POBOX273

Medical Research Council Laboratories, Banjul

Sponsors

Collaborators (1)

Medical Research Council

All Listed Sponsors

collaborator

Medical Research Council

OTHER_GOV

collaborator

National Malaria Control Programme, The Gambia

OTHER_GOV

lead

London School of Hygiene and Tropical Medicine

OTHER